Cell Sorting of Neural Stem and Progenitor Cells from the Adult Mouse Subventricular Zone and Live-imaging of their Cell Cycle Dynamics
September 14th, 2015
16.2K views
We report a Fluorescent Activated Cell Sorting (FACS)-based method to isolate neural stem cells (NSCs) and their progeny from the subventricular zone (SVZ) of the adult mouse brain. Applied to Fluorescence Ubiquitination Cell Cycle Indicator (FUCCI) transgenic mice, it allows the study of cell cycle progression by live imaging.
Overview
This study presents a method for isolating neural stem cells (NSCs) and their progeny from the subventricular zone (SVZ) of adult mouse brains using Fluorescent Activated Cell Sorting (FACS). The approach is applied to FUCCI transgenic mice, enabling live imaging of cell cycle progression.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Stem Cell Research
Background
- Neural stem cells (NSCs) are crucial for brain development and repair.
- The subventricular zone (SVZ) is a key area for neurogenesis in the adult brain.
- Fluorescence Ubiquitination Cell Cycle Indicator (FUCCI) technology allows tracking of cell cycle dynamics.
- FACS is a powerful tool for isolating specific cell populations based on fluorescence.
Purpose of Study
- To develop a reliable method for isolating NSCs and their progeny from the SVZ.
- To study the cell cycle progression of these cells using live imaging techniques.
- To investigate the properties and dynamics of NSCs in the context of aging and brain pathologies.
Methods Used
- Dissection of the SVZ from adult FUCCI transgenic mouse brains.
- Dissociation of neuronal tissue into a single cell suspension using papain treatment.
- Labeling of neurogenic cell populations with specific antibodies.
- Sorting of labeled cells using FACS and subsequent live imaging.
Main Results
- Successful isolation of quiescent and activated NSCs, transit amplifying cells, and neuroblasts.
- Live imaging revealed distinct cell cycle phases in sorted populations.
- Combination of FACS and FUCCI technology enabled detailed analysis of cell dynamics.
- Insights gained into the behavior of NSCs in aging and pathological conditions.
Conclusions
- The developed method is effective for isolating and studying NSCs from the SVZ.
- This approach can enhance understanding of neurogenesis and its implications in brain health.
- Future studies can leverage this technique to explore therapeutic strategies for brain disorders.
Frequently Asked Questions
What is the significance of isolating NSCs?
Isolating NSCs allows researchers to study their properties and roles in neurogenesis and brain repair.
How does FUCCI technology work?
FUCCI technology uses fluorescent proteins to indicate different phases of the cell cycle, enabling live tracking.
What are the applications of this method?
This method can be used to investigate aging, neurodegenerative diseases, and potential regenerative therapies.
What challenges are associated with FACS?
Challenges include ensuring cell viability during sorting and accurately gating for specific populations.
Can this method be applied to other tissues?
While this study focuses on the brain, similar techniques can be adapted for other tissues with stem cell populations.
What is the role of antibodies in this procedure?
Antibodies are used to label specific cell types, allowing for their identification and isolation during FACS.
Executive Industry Relevance
This method enables precise isolation and live imaging of neural stem and progenitor cell populations from the adult mouse subventricular zone, supporting mechanistic de-risking in target validation for neurodegenerative disease research. By linking FACS-based sorting with FUCCI reporters, it provides quantitative, dynamic readouts of cell cycle progression—critical for assessing therapeutic hypotheses in aging and pathology models. The approach enhances predictive confidence in early discovery by enabling reproducible, standardized assays for NSC behavior, directly informing go/no-go decisions in preclinical pipeline advancement.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by isolating defined NSC and progenitor populations for functional target validation.
- Operational Value: Supports biological de-risking through standardized, reproducible sorting of live cells for downstream phenotypic analysis.
- Predictive Confidence: Facilitates portfolio triage by quantifying age-dependent changes in G1 phase length, a biomarker of neurogenic decline.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for compound screening by isolating live, adherent NSCs and progeny with defined cell cycle states.
- Operational Value: Enables assay standardization and reproducibility through FACS isolation and poly-D-lysine plating for consistent time-lapse imaging.
- Scalability: Supports platform reuse across studies by providing a transposable method for NSC isolation and live imaging in adherent culture.
Translational & Preclinical Research
- Disease Relevance: Directly models age-related neurogenesis impairment, offering a disease-relevant system for studying brain pathologies.
- Translational Continuity: Bridges discovery to preclinical validation by enabling longitudinal tracking of cell cycle dynamics in sorted populations.
- Risk-Adjusted Advancement: Informs go/no-go decisions by revealing mechanistic links between aging, G1 prolongation, and neurogenic decline.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from early target validation through lead identification to preclinical assessment, providing a continuous readout of NSC dynamics that supports iterative hypothesis testing and mechanistic de-risking.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling isolation and live imaging of NSC subpopulations defined by LeX/EGFR/CD24 staining.
- Screening: Delivers assay readiness and quantitative outputs via time-lapse video microscopy of FUCCI-labeled cells, enabling comparison of cell cycle phases across conditions.
- Analytics: Generates dynamic, phase-specific fluorescence readouts (red for G1, green for S/G2/M) that allow teams to quantify proliferation kinetics and cell cycle length.
- Translational Research: Connects to preclinical continuity by modeling age-dependent NSC behavior, a key factor in neurodegenerative disease progression.
- Enterprise Reuse: Establishes a reusable capability for NSC isolation and live imaging, adaptable across models and pathologies beyond the adult SVZ.
Operational & Enterprise Impact
- Scientific Value: Provides predictive confidence in target validation by reducing mechanistic ambiguity in NSC cell cycle regulation.
- Operational Value: Ensures standardization, reproducibility, and scalability through FACS isolation and defined culture conditions for live imaging.
- Strategic Value: Improves go/no-go decisions by linking cellular phenotypes to aging-related functional decline, reducing late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization of NSC-targeting strategies based on quantifiable cell cycle dynamics in disease-relevant models.
Implementation Considerations
- Requires expertise in neural tissue dissection, enzymatic dissociation, and multicolor FACS sorting.
- Dependent on access to FACS instrumentation, confocal microscopy, and FUCCI transgenic mouse models.
- Necessitates cross-team standardization of antibody panels, gating strategies, and imaging protocols for reproducible results.
- Involves adaptation considerations when applying the LeX/EGFR/CD24 staining panel to other neural or non-neural stem cell systems.
- Limited by cell viability and sorting duration; prolonged processing increases risk of differentiation or death, particularly with high sample volumes.
Biopharma FAQs
Why does G1 phase length matter for target validation in aging models?
The method reveals that proliferating neural stem cells progressively lengthen their G1 phase during aging, directly linking cell cycle dynamics to neurogenesis impairment. This quantitative readout enables target validation by identifying G1 prolongation as a mechanistic biomarker of functional decline in NSC populations. Measuring this parameter supports predictive confidence in therapeutic hypotheses aimed at rescuing cell cycle regulation in age-related brain pathologies.
How does isolating LeX/EGFR/CD24-positive populations support independent variable isolation in the discovery pipeline?
Using LeX, EGFR, and CD24 triple staining allows precise isolation of quiescent and activated neural stem cells, transit amplifying cells, and neuroblasts as distinct populations. This enables independent variable isolation by defining specific cellular inputs for functional assays, reducing heterogeneity in downstream analyses. Such purification is critical for attributing observed cell cycle differences to defined biological states rather than mixed populations.
What quantitative dependent variable measurements enable cell cycle dynamics analysis?
The FUCCI system provides quantitative, live-cell measurements of cell cycle phase duration through red fluorescence (G1) and green fluorescence (S/G2/M) intensity over time. Time-lapse video microscopy captures the timing of fluorescence transitions, enabling precise measurement of G1, S, G2, and M phase lengths in isolated cells. These dynamic readouts serve as dependent variables for comparing cell cycle behavior across conditions, such as age or treatment.
Why do replication requirements matter for cross-functional collaboration in this workflow?
Replication ensures that observed differences in cell cycle length, such as G1 prolongation in aged mice, are consistent across biological replicates and sorting runs. This reliability is essential for cross-functional teams in discovery, preclinical, and translational science to trust the data for decision-making. Standardized sorting and imaging protocols reduce variability, enabling reproducible results that support collaborative target validation and assay development efforts.
What statistical analysis capabilities are required before implementing this method in a discovery setting?
Implementation requires the ability to quantify fluorescence intensity over time from time-lapse images and compare phase durations across experimental groups using appropriate statistical tests. Teams must be able to assess significance of differences in G1 or S/G2/M phase length between young and aged or treated and control populations. These capabilities are necessary to derive meaningful, data-driven conclusions about NSC dynamics and their relevance to target validation.
